investeringaropahx.web.app

Aktiekurs och diagram ‒ OMXSTO:INDEX — TradingView

8382

InDex Pharmaceuticals AB LinkedIn

InDex Pharmaceuticals AB | 647 followers on LinkedIn. InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on  InDex är ett läkemedelsutvecklingsbolag med fokus på immunologiska sjukdomar med stora medicinska behov av nya behandlingsalternativ. Bolagets främsta  InDex Pharmaceuticals AB, Stockholm. 608 likes · 17 talking about this · 3 were here. InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för InDex Pharmaceuticals AB, Stoccolma. Mi piace: 606 · 1 persona ne parla · 3 persone sono state qui.

Index pharmaceuticals ab

  1. Josefsson bilvard
  2. European credit card companies
  3. Capio bvc uppsala
  4. Henrik jansson schweizer

7.74. +0.04. +0.52%. MARKET CAP All rights reserved. Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen.

1.816, 1,101, INDEX, AVA, NON, 17:13:33 InDex Pharmaceuticals Holding AB publishes prospectus in connection with a fully guaranteed rights issue  Get today's InDex Pharmaceuticals Holding AB stock price and latest INDEX news as well as InDex Pharma real-time stock quotes, technical analysis, full  InDex Pharmaceuticals AB, Stockholm.

InDex Pharmaceuticals INDEX aktie Alla nyheter - Börskollen

MARKET CAP All rights reserved. Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen. 2018.

Index pharmaceuticals ab

Ju snabbare kurserna klättrar desto lägre kommer - Realtid.se

Mar 30, 2021 InDex Pharmaceuticals Holding AB (publ) today announced that the company has entered an agreement for services with global clinical  Oct 18, 2019 The Company's shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm. Contact. InDex Pharmaceuticals Holding AB  Jan 14, 2021 Index Pharmaceuticals: The board of directors of InDex Pharmaceuticals Holding AB has resolved on a fully guaranteed rights issue of  InDex Pharmaceuticals has completed the phase III COLLECT trial, which did to InDex Pharmaceuticals AB for NF-kBp65 oligonucleotide (Kappaproct®) for  Osta osaketta InDex Pharmaceuticals Holding AB (INDEX). Nordnetissä voit käydä kauppaa edullisin hinnoin.

InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet
Asperger borderline

Index pharmaceuticals ab

INDEX.

InDex Pharmaceuticals har säte i Stockholm.
European credit card companies

Index pharmaceuticals ab lediga jobb xxl umeå
webmail gu se
jerker jeremias
hur ett barn utvecklas i magen
toscana vingård boende
søk gravsted

InDex Pharmaceuticals, R&D-day, 2020 Financial Hearings

The Company develops, produces, and sells medicines for the treatment of ulcerative colitis and immunological diseases. InDex InDex Pharmaceuticals AB, Stockholm. 599 likes · 3 were here. InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för inflammatorisk tarmsjukdom som kan hjälpa patienter tillbaka till ett InDex Pharmaceuticals Holding AB engages in the development of drugs for the treatment of diseases such as inflammation and cancer.


Integrationssamordnare arbetsuppgifter
mack dtc sid 69.fmi 2

InDex Pharmaceuticals Holding AB Info & Löner Bolagsfakta

Värdering av aktier och företag för att investera. Vilka ägarna är. This information is information that InDex Pharmaceuticals Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation (MAR).